A phase 1 trial IMU-838 in hepatic impaired patients
Latest Information Update: 12 May 2021
At a glance
- Drugs Vidofludimus calcium (Primary)
- Indications Liver disorders
- Focus Adverse reactions
- 12 May 2021 New trial record
Latest Information Update: 12 May 2021